De-Risking the Neurology IND: Lessons from Early FDA Engagement
Developing therapies for neurological diseases represents one of the most challenging frontiers in modern biotechnology. With subjective clinical...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
1 min read
Veristat Blog : Published Updated
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications, breakthrough therapy designations, and innovative trial solutions across rare and ultra-rare neurological disorders.
With 250+ clinical trials and projects completed in the past 10 years, we bring proven expertise to the most challenging neuroscience therapeutic areas. Our diverse trial experience includes drug, biologic, and diagnostic trials—including pediatric gene therapy, stroke cell therapy, and psychiatric NDA submissions, with more than 30% focused on rare or ultra-rare neurological diseases.
In our neurology/psychiatry portfolio, learn how our team has helped sponsors to solve challenges across numerous areas including:
Pediatric gene therapy advancement
Strategic NDA/BLA submission support
Complex stroke therapy logistics
Rare disease trial management
Regulatory approval navigation (FDA, EMA, and regional agencies)
International family coordination

Developing therapies for neurological diseases represents one of the most challenging frontiers in modern biotechnology. With subjective clinical...
Developing advanced therapies for neurology is often described as a “perfect storm of complexity.” These studies face scientific, operational, and...
Developing treatments for neurological, psychiatric, or CNS disorders means navigating complex trial designs, subjective endpoints, and global...